Alumis

About:

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Twitter/X: EskerTx

Top Investors: Samsara BioCapital, Cormorant Asset Management, venBio Partners, Foresite Capital, SR One

Description:

Alumis develops precision medications to treat autoimmune illnesses. The company's analytics platform and understanding of immunologic disorders aid in the development of treatments and medications for autoimmune diseases, allowing patients to alleviate suffering and modify their way of life.

Total Funding Amount:

$529M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2021-01-01

Contact Email:

hello(AT)eskertx.com

Founders:

June Lee

Number of Employees:

11-50